Comorbidity is very common among patients with cancer. Multidisciplinary team meetings (MDTs) are increasingly the context within which cancer treatment decisions are made internationally. Little is known about how comorbidity is considered, or impacts decisions, in MDTs. MDTs should systematically consider treatment of patients with comorbidity.
READ FULL ARTICLE From Mdlinx